122 related articles for article (PubMed ID: 2462981)
1. Monocyte monolayer assay (MMA)--an efficient method for predicting the clinical significance of alloantibodies and the severity of hemolytic disease of the newborn.
Garratty G
Beitr Infusionsther; 1988; 21():236-9. PubMed ID: 2462981
[No Abstract] [Full Text] [Related]
2. [Functional evaluation of erythrocytic antibodies by photometric detection of erythrophagocytosis in the monocyte monolayer assay].
Cassens U; Garritsen HS; Sibrowski W; Holzgreve W
Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):297-300. PubMed ID: 8766487
[TBL] [Abstract][Full Text] [Related]
3. The monocyte monolayer assay: a noninvasive technique for predicting the severity of in utero hemolysis.
Larson PJ; Thorp JM; Miller RC; Hoffman M
Am J Perinatol; 1995 May; 12(3):157-60. PubMed ID: 7612085
[TBL] [Abstract][Full Text] [Related]
4. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis].
Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H
Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424
[TBL] [Abstract][Full Text] [Related]
5. Assessment of severity of haemolytic disease of newborn by monocyte monolayer assay.
Dhingra-Kumar N; Duguid JK; Bromilow IM
Indian J Med Res; 1995 Aug; 102():71-6. PubMed ID: 8834817
[TBL] [Abstract][Full Text] [Related]
6. [Prenatal diagnosis and prevention of hemolytic disease of newborn].
Fischer K
Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():64-9. PubMed ID: 8374293
[TBL] [Abstract][Full Text] [Related]
7. [Clinical aspects of Rh incompatibility. II. Discrepancy between high anti-D titer and incipient mild hemolytic disease of the newborn].
Gmyrek D; Reitzig C; Schubert S; Syllm-Rapoport I
Dtsch Gesundheitsw; 1971 Apr; 26(15):687-92. PubMed ID: 5103567
[No Abstract] [Full Text] [Related]
8. Clinical application of functional assays for assessing the red cell antibody activity.
Zupańska B
Transfus Sci; 1993 Oct; 14(4):371-81. PubMed ID: 10146644
[TBL] [Abstract][Full Text] [Related]
9. Use of the erythrophagocytosis assay for predicting the clinical consequences of immune blood cell destruction.
Biondi CS; Cotorruelo CM; Ensinck A; Racca LL; Racca AL
Clin Lab; 2004; 50(5-6):265-70. PubMed ID: 15209434
[TBL] [Abstract][Full Text] [Related]
10. Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn.
Sacks DA; Nance SJ; Garratty G; Petrucha RA; Horenstein J; Fotheringham N
Am J Perinatol; 1993 Nov; 10(6):428-31. PubMed ID: 8267805
[TBL] [Abstract][Full Text] [Related]
11. [A fluorescence monolayer assay in the study of the function of human blood monocytes].
Schwartz D
Beitr Infusionsther; 1988; 21():240-2. PubMed ID: 2462983
[No Abstract] [Full Text] [Related]
12. ABO haemolytic disease of the newborn: laboratory prediction and post-natal diagnosis.
Lockyer WJ
Med Lab Sci; 1982 Jul; 39(3):287-95. PubMed ID: 6752621
[No Abstract] [Full Text] [Related]
13. Correlation of monocyte-monolayer assay results, number of erythrocyte-bound IgG molecules, and IgG subclass composition in the study of red cell alloantibodies other than D.
Zupańska B; Brojer E; McIntosh J; Seyfried H; Howell P
Vox Sang; 1990; 58(4):276-80. PubMed ID: 2399692
[TBL] [Abstract][Full Text] [Related]
14. [Prenatal diagnosis and therapy of hemolytic disease of the newborn].
Fischer K; Poschmann A; Hellwege HH; Kitschke HJ; Carstensen M; Sprotte C; Schreer I
Monatsschr Kinderheilkd; 1985 Mar; 133(3):167-70. PubMed ID: 4010672
[TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies.
Arndt PA; Garratty G
Transfusion; 2004 Sep; 44(9):1273-81. PubMed ID: 15318848
[TBL] [Abstract][Full Text] [Related]
16. Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test.
Lucas GF; Hadley AG; Nance SJ; Garratty G
Transfusion; 1993 Jun; 33(6):484-7. PubMed ID: 8516790
[TBL] [Abstract][Full Text] [Related]
17. [The importance of unusual isoimmunizations in the prophylaxis of hemolytic disease of the newborn].
Joó-Szabados T; Neubauer G; Székessy V; Wohlmuth G
Acta Paediatr Acad Sci Hung; 1970; 11(2):111-4. PubMed ID: 5504582
[No Abstract] [Full Text] [Related]
18. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay.
Nance SJ; Arndt P; Garratty G
Transfusion; 1987; 27(6):449-52. PubMed ID: 3686653
[TBL] [Abstract][Full Text] [Related]
19. [Lan antigen of erythrocytes and clinical significance of anti-Lan antibody].
Kuśnierz-Alejska G; Wiecek B
Acta Haematol Pol; 1993; 24(2):169-75. PubMed ID: 8372617
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic and prognostic significance of erythrocyte adenosine triphosphatase activity changes in hemolytic disease in the newborn].
Osipov AI
Vopr Okhr Materin Det; 1969 Feb; 14(2):90. PubMed ID: 4241957
[No Abstract] [Full Text] [Related]
[Next] [New Search]
